This AI trading robot from Day Trader ($2K per position): Medium Volatility Stocks for Active Trading (TA&FA), was a top performer in our robot factory over a month, generating 7.11% for OCGN.
OCGN, a medium volatility stock, has been actively traded using both technical analysis (TA) and fundamental analysis (FA) through an AI trading robot from Day Trader that costs $2K per position. This trading robot has been a top performer in the robot factory over a month, generating a 7.11% return for OCGN. However, the recent MACD histogram turning negative on April 25, 2023, is a bearish signal indicating a potential decline in the stock's price going forward.
Tickeron's A.I.dvisor has conducted a historical analysis on 49 instances where the MACD histogram turned negative, revealing that in 47 of the 49 cases, the stock moved lower in the following days. This puts the odds of a downward move at 90%. Therefore, traders and investors should be cautious when trading OCGN, especially given the current bearish signal.
Fundamentally, OCGN's last earnings report on February 28 showed earnings per share of -10 cents, meeting the estimate of -10 cents. This indicates that the company is meeting expectations but not generating a profit yet. With 732.65K shares outstanding, the current market capitalization sits at 163.03M, reflecting the stock's perceived value by the market.
The technical analysis of OCGN's MACD histogram indicates a potential decline in the stock's price going forward, and the fundamental analysis shows that the company is not yet generating a profit. These factors should be taken into consideration by traders and investors when making trading decisions on OCGN.
The Aroon Indicator for OCGN entered a downward trend on May 30, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 243 similar instances where the Aroon Indicator formed such a pattern. In of the 243 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on May 17, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on OCGN as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for OCGN turned negative on May 24, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCGN advanced for three days, in of 205 cases, the price rose further within the following month. The odds of a continued upward trend are .
OCGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OCGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.592) is normal, around the industry mean (25.115). P/E Ratio (0.000) is within average values for comparable stocks, (123.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.372). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (308.870).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, OCGN has been closely correlated with INO. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if OCGN jumps, then INO could also see price increases.
Ticker / NAME | Correlation To OCGN | 1D Price Change % | ||
---|---|---|---|---|
OCGN | 100% | -0.21% | ||
INO - OCGN | 66% Closely correlated | -1.91% | ||
BEAM - OCGN | 66% Loosely correlated | +1.15% | ||
EDIT - OCGN | 65% Loosely correlated | +8.58% | ||
VXRT - OCGN | 64% Loosely correlated | -2.36% | ||
SANA - OCGN | 62% Loosely correlated | +1.93% | ||
More |